These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32013679)

  • 1. Identification and characterisation of fluorescent substances in spent dialysis fluid.
    Meibaum J; Krause S; Hillmer H; Marcelli D; Strohhöfer C
    Int J Artif Organs; 2020 Sep; 43(9):579-586. PubMed ID: 32013679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid-chromatographic study of fluorescent compounds in hemodialysate solutions.
    Barnett AL; Veening H
    Clin Chem; 1985 Jan; 31(1):127-30. PubMed ID: 3917379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients.
    Paats J; Adoberg A; Arund J; Dhondt A; Fernström A; Fridolin I; Glorieux G; Leis L; Luman M; Gonzalez-Parra E; Perez-Gomez VM; Pilt K; Sanchez-Ospina D; Segelmark M; Uhlin F; Arduan Ortiz A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum substances that interfere with thyroid hormone assays in patients with chronic renal failure.
    Iitaka M; Kawasaki S; Sakurai S; Hara Y; Kuriyama R; Yamanaka K; Kitahama S; Miura S; Kawakami Y; Katayama S
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):739-46. PubMed ID: 9713563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of removed uremic toxin indoxyl sulphate during hemodialysis by using optical data of the spent dialysate.
    Holmar J; Uhlin F; Ferenets R; Lauri K; Tanner R; Arund J; Luman M; Fridolin I
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():6707-10. PubMed ID: 24111282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Fluorescence Valid to Monitor Removal of Protein Bound Uremic Solutes in Dialysis?
    Arund J; Luman M; Uhlin F; Tanner R; Fridolin I
    PLoS One; 2016; 11(5):e0156541. PubMed ID: 27228162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
    Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
    Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid-chromatographic study of fluorescent materials in uremic fluids.
    Swan JS; Kragten EY; Veening H
    Clin Chem; 1983 Jun; 29(6):1082-4. PubMed ID: 6851098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of indole-3-acetic acid, tryptophan and other indoles in must and wine by high-performance liquid chromatography with fluorescence detection.
    Mattivi F; Vrhovsek U; Versini G
    J Chromatogr A; 1999 Sep; 855(1):227-35. PubMed ID: 10514987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Pyridoxic Acid in the Spent Dialysate: Contribution to Fluorescence and Optical Monitoring.
    Kalle S; Tanner R; Arund J; Tomson R; Luman M; Fridolin I
    PLoS One; 2016; 11(9):e0162346. PubMed ID: 27598005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid-chromatographic profiling of endogenous fluorescent substances in sera and urine of uremic and normal subjects.
    Mabuchi H; Nakahashi H
    Clin Chem; 1983 Apr; 29(4):675-7. PubMed ID: 6831696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do only small uremic toxins, chromophores, contribute to the online dialysis dose monitoring by UV absorbance?
    Arund J; Tanner R; Uhlin F; Fridolin I
    Toxins (Basel); 2012 Oct; 4(10):849-61. PubMed ID: 23162701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Indoxyl Sulfate Dialyzer Clearance with the Use of Binding Competitors.
    Tao X; Thijssen S; Levin N; Kotanko P; Handelman G
    Blood Purif; 2015; 39(4):323-30. PubMed ID: 25998324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On-line monitoring of solutes in dialysate using absorption of ultraviolet radiation: technique description.
    Fridolin I; Magnusson M; Lindberg LG
    Int J Artif Organs; 2002 Aug; 25(8):748-61. PubMed ID: 12296459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of Urea, β2-Microglobulin, and Indoxyl Sulfate Assessed by Absorbance and Fluorescence in the Spent Dialysate During Hemodialysis.
    Lauri K; Arund J; Holmar J; Tanner R; Kalle S; Luman M; Fridolin I
    ASAIO J; 2020 Jun; 66(6):698-705. PubMed ID: 31425267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure.
    MacPhee IA; Spreafico S; Bewick M; Davis C; Eastwood JB; Johnston A; Lee T; Holt DW
    Kidney Int; 2000 Mar; 57(3):1164-8. PubMed ID: 10720968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical elucidation and HPLC fractionation of fluorescent peptides in patients with chronic renal failure.
    Williams RH; Dubin A; Shaykh M; Musiala T; Ahmed S; Bazilinski N; Dunea G
    Adv Exp Med Biol; 1987; 223():205-13. PubMed ID: 3447437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free Pentosidine Assessment Based on Fluorescence Measurements in Spent Dialysate.
    Kalle S; Tanner R; Luman M; Fridolin I
    Blood Purif; 2019; 47(1-3):85-93. PubMed ID: 30253381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of pantoprazole in patients with end-stage renal failure.
    Kliem V; Bahlmann J; Hartmann M; Huber R; Lühmann R; Wurst W
    Nephrol Dial Transplant; 1998 May; 13(5):1189-93. PubMed ID: 9623552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoxyl-beta-D-glucuronide and 3-indoxyl sulfate in plasma of hemodialysis patients.
    Agatsuma S; Sekino H; Watanabe H
    Clin Nephrol; 1996 Apr; 45(4):250-6. PubMed ID: 8861801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.